Benoquin 30 Cream (Monobenzone) – Vitiligo Depigmentation Treatment

Buy Benoquin 30 Cream from Tabexports – Global Medicine Exporter

Benoquin 30 Cream (Monobenzone 30%) is a dermatological medication used for depigmentation therapy in patients with extensive vitiligo. It helps create a more uniform skin tone by reducing melanin production in normal skin areas. The active ingredient Monobenzone works by gradually destroying melanocytes, the cells responsible for skin pigmentation.

Tabexports supplies Benoquin 30 Cream for international pharmaceutical markets, offering bulk export, wholesale supply, and reliable global delivery to United States, United Kingdom, Australia, France, Thailand, and worldwide healthcare distributors.

Active Ingredient

• Monobenzone 30%

Monobenzone is a skin depigmenting agent used in dermatology to help achieve permanent depigmentation in patients with widespread vitiligo.

Medical Uses

✔ Treatment of extensive vitiligo
✔ Depigmentation therapy for uneven skin pigmentation
✔ Helps achieve uniform skin color
✔ Dermatological treatment for pigment disorders

⚠ Use only under the supervision of a qualified dermatologist.

Key Benefits

• Effective vitiligo depigmentation treatment

• Helps achieve even skin tone

• Dermatologist-recommended therapy for severe vitiligo

• 30% Monobenzone formulation suitable for controlled depigmentation

• Widely used in dermatology practice

Directions for Use

1. Clean and dry the affected skin area.

2. Apply a thin layer of Benoquin 30 Cream to pigmented areas.

3. Use once or twice daily as prescribed by a doctor.

4. Avoid excessive sun exposure while using the medicine.

Storage Instructions

• Store below 25°C

• Protect from direct sunlight and moisture

• Keep out of reach of children

Why Choose Tabexports?

🌍 Worldwide pharmaceutical exporter
📦 Bulk medicine supply for distributors and wholesalers
🚚 Reliable international shipping
🏭 High-quality pharmaceutical sourcing
📈 Trusted global healthcare supplier

Tabexports exports Benoquin 30 Cream (Monobenzone) to USA, UK, Australia, France, Thailand, and worldwide pharmaceutical markets.